- Broad and potent immune responses demonstrated with full length Spike protein antigen - Large animal studies and COVID variant testing planned - Facilitates development of a heat-stable vaccine candidate, avoiding refrigeration or freezing PRINCETON, N.J., March 4, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused… Read More..
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its clinical product candidate, cavrotolimod (AST-008), for the treatment of patients with… Read More..
Video Presentation Available at: https://ecochainmining.com/news/ecochain-inc-announces-strategic-update ALBANY, N.Y., March 2, 2021 /PRNewswire/ -- EcoChain, Inc. ("EcoChain"), a wholly-owned subsidiary of Mechanical Technology, Incorporated ("MTI" or the "Company"), (OTCQB: MKTY), a cryptocurrency mining business powered by renewable energy, announced today the release of a strategic update discussing how EcoChain is setting the… Read More..